Solabia Xebios GmbH

Solabia Xebios GmbH specializes in microbiological culture media and diagnostic reagents. Their products include agar-based media like potato dextrose agar, Sabouraud dextrose agar (modified with chloramphenicol), and selective/enrichment media such as xylose lysine deoxycholate medium and buffered peptone water with Tween 80. They also produce specialized formulations like CHROMagar™ Orientation, Dermasel agar (with chloramphenicol/cycloheximide), and modified Staphylococcus broth. These are primarily used in microbiological testing and diagnostics.

Solabia Xebios GmbH is based in Germany, which places its devices under the jurisdiction of the European Union’s Medical Device Regulation (MDR). Since the company’s products are listed in the EUDAMED database, they are intended for the European market and comply with MDR requirements. The German location ensures alignment with EU regulatory frameworks, including classification and mandatory reporting.

All of Solabia Xebios GmbH’s listed devices fall under Class A classification in the EU Medical Device Regulation (MDR). This classification applies because these products are microbiological culture media and diagnostic reagents, which pose minimal risk to patients and users. Class A devices typically undergo streamlined conformity assessment procedures, though they still require compliance with essential safety and performance requirements.

Solabia Xebios GmbH’s devices are listed in the EUDAMED database, which is the official European Union registry for medical devices. EUDAMED ensures transparency by tracking device information, including manufacturer details, device identification, and regulatory status. Listing in EUDAMED is mandatory for devices placed on the European market, confirming their compliance with MDR requirements.

Solabia Xebios GmbH’s products are classified as Class A because they are low-risk microbiological culture media and diagnostic reagents designed for in vitro use. Unlike higher-risk devices (e.g., implants or active medical devices), Class A products primarily interact with biological samples in controlled laboratory settings, reducing patient and user risk. This classification means users can rely on these products for routine microbiological testing with confidence in their safety and performance, though compliance with MDR guidelines remains essential for proper use.